Atlas Trials

Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

Clinical trial NCT02396134 · COMPLETED

Trial details

NCT number
NCT02396134
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in RemissionAdult Hodgkin LymphomaAdult Non-Hodgkin LymphomaChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveCytomegaloviral InfectionHematopoietic and Lymphoid Cell NeoplasmHLA-A*0201 Positive Cells PresentMyelodysplastic SyndromeAdult Lymphoblastic LymphomaChronic Lymphocytic Leukemia
Start date
2015-05-21
Primary completion
2018-03-04
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.